Insider buying · SEC Form 4

SMMT insider buying

Open-market purchases of Summit Therapeutics Inc. (SMMT) stock by its own executives, directors and 10% owners — every Form 4 buy of $250K or more that SPX Lens's daily insider scan has recorded, newest first.

3insider buys on record
$3.64Mbought in total
3different insiders
3by CEOs, CFOs and other chiefs
Jun 8, 2026latest scan with a buy

Every recorded buy

ScanInsiderValueSharesAvg priceTypeFiled
Jun 8, 2026Robert W. DugganCo-CEO / Director$1.46M100,000$14.60AddedJun 8, 2026
Transaction June 4 at $14.60 (Nasdaq −4% day); now $14.77 (+1.2%). Indirect purchase via associated trust. Part of tri-insider cluster buy: Duggan + Zanganeh (co-CEO) + Soni (COO-CFO) all bought same day. Awaiting FDA review date for ivonescimab.
Jun 8, 2026Mahkam ZanganehCo-CEO / Director$1.46M100,000$14.60AddedJun 8, 2026
Transaction June 4 at $14.60 (Nasdaq −4% day); now $14.77 (+1.2%). Mahkam Zanganeh Revocable Trust; post-purchase trust holds 25.8M shares. Cluster buy alongside Duggan and Soni on the same day. June 2 company 8-K had authorized affiliate purchases under ATM program.
Jun 8, 2026Manmeet Singh SoniCOO / CFO / Director$722K50,000$14.45AddedJun 8, 2026
Transaction June 4: 25,000 shares at $14.43 + 25,000 shares at $14.46; now $14.77 (+2.3%). Post-purchase direct holdings: 3,123,603 shares. Third SMMT insider buying on June 4 alongside both co-CEOs into the market selloff.

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.